Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 14201-14250 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04250116
Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents
PHASE4Active, not recruiting
960 participants
Started: Apr 28, 2020 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04380753
AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).
PHASE1Active, not recruiting
12 participants
Started: Apr 28, 2020 · Completed: Jun 16, 2026
1 condition1 sponsor4 locations
NCT04311788
Preemer Trial - Prophylactic Mesh Versus no Mesh in the Midline Emergency Laparotomy Closure for Prevention of Incisional Hernia: a Multi Center, Double-blind, Randomized Controlled Trial
NAActive, not recruiting
109 participants
Started: Apr 27, 2020 · Completed: Mar 31, 2028
4 conditions2 sponsors7 locations
NCT04157153
First in Men Study: BIOMAG-I
NAActive, not recruiting
116 participants
Started: Apr 27, 2020 · Completed: Feb 28, 2027
1 condition1 sponsor14 locations
NCT04367805
COVID-19 Infection in Patients With Hepatocellular Carcinoma
N/AActive, not recruiting
23 participants
Started: Apr 27, 2020 · Completed: Oct 31, 2024
2 conditions17 sponsors1 location
NCT04370119
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
N/AActive, not recruiting
1,092 participants
Started: Apr 27, 2020 · Completed: May 31, 2025
1 condition3 sponsors1 location
NCT04264702
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
N/AActive, not recruiting
1,788 participants
Started: Apr 24, 2020 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT04130854
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
PHASE2Active, not recruiting
58 participants
Started: Apr 24, 2020 · Completed: Dec 5, 2025
1 condition2 sponsors4 locations
NCT03992456
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
PHASE2Active, not recruiting
12 participants
Started: Apr 24, 2020 · Completed: Oct 7, 2024
30 conditions2 sponsors18 locations
NCT04375267
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours
PHASE1Active, not recruiting
18 participants
Started: Apr 23, 2020 · Completed: Jun 30, 2024
4 conditions2 sponsors1 location
NCT03934567
A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
PHASE2Active, not recruiting
87 participants
Started: Apr 22, 2020 · Completed: Oct 30, 2025
1 condition1 sponsor26 locations
NCT04214288
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
PHASE2Active, not recruiting
240 participants
Started: Apr 22, 2020 · Completed: Mar 17, 2026
1 condition1 sponsor91 locations
NCT06419426
Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)
N/AActive, not recruiting
2,000 participants
Started: Apr 22, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor25 locations
NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
260 participants
Started: Apr 22, 2020 · Completed: Aug 31, 2026
4 conditions2 sponsors21 locations
NCT02989948
Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA
NAActive, not recruiting
38 participants
Started: Apr 22, 2020 · Completed: Dec 31, 2031
1 condition1 sponsor1 location
NCT04388605
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
N/AActive, not recruiting
7,965 participants
Started: Apr 21, 2020 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04343885
In Men With Metastatic Prostate Cancer, What is the Safety and Benefit of Lutetium-177 PSMA Radionuclide Treatment in Addition to Chemotherapy
PHASE2Active, not recruiting
130 participants
Started: Apr 21, 2020 · Completed: Mar 31, 2026
1 condition9 sponsors12 locations
NCT04687475
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
NAActive, not recruiting
10 participants
Started: Apr 20, 2020 · Completed: Jun 1, 2026
2 conditions1 sponsor1 location
NCT04358107
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
N/AActive, not recruiting
1,000 participants
Started: Apr 20, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06420687
GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices
NAActive, not recruiting
45 participants
Started: Apr 20, 2020 · Completed: Sep 30, 2025
4 conditions2 sponsors1 location
NCT04393649
First Level Socio-geriatric Evaluation: ESOGER Databank
N/AActive, not recruiting
20,000 participants
Started: Apr 20, 2020 · Completed: Apr 19, 2027
4 conditions1 sponsor1 location
NCT03532295
Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
PHASE2Active, not recruiting
51 participants
Started: Apr 20, 2020 · Completed: Apr 25, 2026
2 conditions2 sponsors4 locations
NCT04375982
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
NAActive, not recruiting
200 participants
Started: Apr 20, 2020 · Completed: Mar 31, 2024
3 conditions1 sponsor4 locations
NCT04368234
Duke COVID-19 Shared Data and Specimen Repository
N/AActive, not recruiting
100,000 participants
Started: Apr 18, 2020 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT04603287
A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors
PHASE1Active, not recruiting
60 participants
Started: Apr 17, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors3 locations
NCT05694819
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
PHASE2Active, not recruiting
56 participants
Started: Apr 17, 2020 · Completed: Mar 31, 2026
1 condition2 sponsors12 locations
NCT03965689
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy
PHASE2Active, not recruiting
27 participants
Started: Apr 16, 2020 · Completed: Mar 18, 2026
8 conditions1 sponsor10 locations
NCT04305496
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
PHASE3Active, not recruiting
818 participants
Started: Apr 16, 2020 · Completed: Jun 7, 2024
1 condition1 sponsor215 locations
NCT05440370
Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage Defects
NAActive, not recruiting
90 participants
Started: Apr 16, 2020 · Completed: Jan 31, 2027
1 condition1 sponsor4 locations
NCT04798378
NuroSleeve Powered Brace & Stimulation System to Restore Arm Function
NAActive, not recruiting
20 participants
Started: Apr 16, 2020 · Completed: Dec 31, 2026
14 conditions1 sponsor2 locations
NCT04456361
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
EARLY_PHASE1Active, not recruiting
9 participants
Started: Apr 16, 2020 · Completed: Nov 15, 2025
2 conditions1 sponsor1 location
NCT04568148
COVID-19 Biorepository
N/AActive, not recruiting
201 participants
Started: Apr 15, 2020 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04768101
Quantitative Imaging of Brain Glymphatic Function in Humans
EARLY_PHASE1Active, not recruiting
140 participants
Started: Apr 15, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04783571
Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia
NAActive, not recruiting
70 participants
Started: Apr 13, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04023591
Nerve Transfer After Spinal Cord Injury- Multi-center
N/AActive, not recruiting
70 participants
Started: Apr 13, 2020 · Completed: Dec 31, 2026
3 conditions10 sponsors9 locations
NCT04184050
Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)
PHASE1Active, not recruiting
100 participants
Started: Apr 13, 2020 · Completed: Jun 30, 2026
4 conditions1 sponsor12 locations
NCT04427930
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
PHASE3Active, not recruiting
129 participants
Started: Apr 13, 2020 · Completed: Dec 30, 2027
1 condition1 sponsor4 locations
NCT04147351
A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors.
PHASE2Active, not recruiting
22 participants
Started: Apr 10, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04343573
Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors
PHASE2Active, not recruiting
102 participants
Started: Apr 10, 2020 · Completed: Apr 30, 2026
1 condition2 sponsors7 locations
NCT04045717
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0
PHASE2Active, not recruiting
124 participants
Started: Apr 10, 2020 · Completed: Feb 16, 2032
3 conditions4 sponsors3 locations
NCT04341142
Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER
NAActive, not recruiting
550 participants
Started: Apr 10, 2020 · Completed: Oct 10, 2026
1 condition1 sponsor1 location
NCT04655469
Personal Health Train for Radiation Oncology in India and The Netherlands
N/AActive, not recruiting
2,000 participants
Started: Apr 10, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT04214067
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer
PHASE3Active, not recruiting
168 participants
Started: Apr 9, 2020 · Completed: Dec 30, 2025
3 conditions2 sponsors280 locations
NCT04081220
Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential Thrombocythemia (ET), Ph 2
PHASE2Active, not recruiting
9 participants
Started: Apr 9, 2020 · Completed: Dec 20, 2026
1 condition2 sponsors1 location
NCT04359602
COVID-19 Recovered Volunteer Research Participant Pool Registry
N/AActive, not recruiting
5,090 participants
Started: Apr 8, 2020 · Completed: Apr 20, 2042
1 condition1 sponsor1 location
NCT04048655
Reversal of Neuromuscular Blockade During the General Anaesthesia
NAActive, not recruiting
120 participants
Started: Apr 8, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04360538
Long Term Outcomes of Patients With COVID-19
N/AActive, not recruiting
500 participants
Started: Apr 8, 2020 · Completed: Nov 1, 2025
4 conditions1 sponsor1 location
NCT04585074
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery
N/AActive, not recruiting
2,000 participants
Started: Apr 8, 2020 · Completed: Apr 7, 2030
5 conditions1 sponsor18 locations
NCT04268550
Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)
PHASE2Active, not recruiting
124 participants
Started: Apr 8, 2020 · Completed: Mar 1, 2026
4 conditions2 sponsors306 locations
NCT04234061
Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
PHASE2Active, not recruiting
20 participants
Started: Apr 7, 2020 · Completed: Sep 1, 2030
1 condition2 sponsors1 location